Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal 'off' periods causing sleep disruption in Parkinson's disease

European Journal of Neurology

Volumn 8, Issue SUPPL. 1, 2001, Pages 8-11

  Ghatani, T ^a   Agapito, C ^a   Bhattacharya, K F ^a   Clough, C ^a   Chaudhuri, K R ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; LEVODOPA; PERGOLIDE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MENTAL DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 0035065202     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Bladder hyperreflexia induced in marmosets by l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
2. Differential effects of three dopamine receptor agonists in MPTP-treated monkeys
3. Sleep in Parkinson's disease
4. Pergolide monotherapy in the treatment of early PD. A randomized controlled study
5. Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease
6. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
7. Pharmacodynamic and pharmacokinetic features of cabergoline
8. Pergolide: A dopamine agonist at both D1 and D2 receptors
9. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
10. The use of cabergoline in nocturnal parkinsonian disabilities causing sleep disruption: A parallel study with controlled-release levodopa
11. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
12. Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations
13. Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias
14. Cabergoline versus Pergolide. A video blinded, randomised, multicentre, crossover study
15. Treatment of restless leg syndrome with pergolide - An open clinical trial
16. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)